Dr. Katherine Ferrara's lab focuses on developing advanced imaging technologies to enhance medical procedures, particularly in the fields of interventional radiology and oncology. The lab is working on innovative ultrasound imaging techniques that can provide high-resolution images without radiation exposure, making it safer for patients undergoing procedures like biopsies and treatments for liver and breast cancer. They are also developing specialized imaging systems for children and investigating targeted therapies for pancreatic cancer.

Dr. Ruijiang Li's lab focuses on developing advanced imaging techniques and blood-based biomarkers to personalize cancer treatments, particularly for lung, oropharyngeal, gastric, and rectal cancers. The research aims to enhance prediction of patient responses to immunotherapy and other treatments, which could ultimately improve outcomes and help tailor therapies to individual patients' needs.

Dr. Daniel M Spielman's lab at Stanford University is focused on innovative cancer therapies and imaging techniques. Their aim is to improve the treatment and diagnosis of resistant cancers like glioblastoma by utilizing novel lipid-based drugs that target tumor energy metabolism. By developing advanced MRI techniques, the lab is working to better understand metabolic changes in tumors and enhance treatment response monitoring.

The lab led by Dr. Akshay Chaudhari at Stanford University focuses on improving cardiovascular disease risk prediction using advanced deep learning techniques. By analyzing existing abdominal CT scans and electronic medical records, the lab aims to develop new algorithms that enhance the accuracy of risk assessments for conditions such as heart attacks and strokes. Their work not only seeks to refine traditional prediction methods but also to promote health equity by ensuring accurate evaluation across diverse populations.

Dr. Jeremy Dahl's lab focuses on creating advanced imaging technology to improve the early detection of breast cancer. Their primary project involves developing a specialized ultrasound molecular imaging system designed to target a protein called B7-H3, which is closely associated with breast cancer. This innovative approach aims to enhance diagnostic accuracy and potentially allow for the earlier identification of metastatic disease, ultimately offering better treatment options for patients.

Dr. Kawin Setsompop's research lab at Stanford focuses on advancing diffusion MRI technology to obtain high-resolution images of the brain. By developing new imaging methods, the lab aims to improve our understanding of brain microstructures and their implications for various neurological disorders. The team's work involves creating innovative tools to capture detailed information about brain connectivity and abnormalities, leading to potential breakthroughs in clinical applications and foundational neuroscience.

Dr. Lei Stanley Qi's lab at Stanford University focuses on understanding how the spatial organization of mRNA in cells affects both normal cellular functions and disease mechanisms. The team develops new technologies to track and manipulate the localization of mRNAs within cells, particularly in neurons, to investigate their roles in processes like axon development and synaptic activity. By studying how mislocalized mRNA contributes to diseases such as ALS and spinal muscular atrophy, the lab aims to uncover innovative therapeutic strategies.

Dr. Quynh-Thu Xuan Le's research lab at Stanford University focuses on improving radiotherapy for cancer treatment. By studying how cancer and normal tissues respond to radiation, the lab aims to protect healthy cells while enhancing the effectiveness of therapies against tumors. They are investigating various molecular strategies, including the use of natural compounds and genetic pathways, to develop more effective cancer treatments with fewer side effects.

Dr. Jennifer A McNab's lab focuses on improving the treatment options for patients with epilepsy, especially those who do not show visible brain lesions using traditional imaging methods. By developing advanced diffusion MRI techniques, the lab aims to accurately locate the areas in the brain where seizures originate, helping neurosurgeons target these areas more effectively. The research could significantly enhance the chances of successful surgery for epilepsy patients, leading to better outcomes and potentially curative treatments.

Dr. Michael Fischbach's lab at Stanford University focuses on harnessing the power of the human microbiome to create innovative vaccines. By engineering certain beneficial bacteria to target diseases like cancer and autoimmune conditions, the lab aims to develop solutions that are effective, durable, and easy to distribute, particularly in low-resource settings. This research combines cutting-edge technologies from immunology and microbiology to redefine how vaccines can be designed and applied.

Dr. Karl Deisseroth's lab at Stanford University focuses on understanding how brain states influence neural activity and behavior. By developing advanced imaging and computational techniques, the lab seeks to reveal how different types of neurons interact during various brain states and how these interactions affect sensory perception and behavior. This work is essential for shedding light on the mechanisms behind mental processes and could lead to improved treatments for neurological and psychiatric disorders.

Dr. Feliks Kogan's research lab at Stanford University focuses on innovative imaging techniques for studying osteoarthritis (OA), a condition impacting millions by causing pain and disability. The lab aims to develop new non-invasive MRI methods to assess inflammation in joints without needing contrast agents, helping to understand and monitor the disease better. They also explore how physiological stress affects joint response and metabolism, particularly across different ages and sexes, to improve early detection and treatment strategies for OA.

Dr. Mirabela Rusu's lab at Stanford University focuses on using advanced imaging techniques to improve the diagnosis of prostate cancer. By developing deep learning models that analyze MRI scans, the lab aims to distinguish between aggressive and indolent forms of prostate cancer, which is crucial for preventing unnecessary biopsies and improving patient care. Their innovative approach combines pathology data with imaging to enhance the accuracy of cancer detection.

Dr. Lei Xing's lab at Stanford University focuses on improving radiation therapy through advanced quality assurance tools that utilize artificial intelligence (AI). The lab develops deep learning models that enhance the accuracy and reliability of treatment plans in radiation oncology, ensuring better patient care. Their work aims to streamline the workflow in radiation therapy and make treatment safer and more efficient for patients.

Dr. Jianghong Rao's lab at Stanford University focuses on improving the effectiveness of radiation therapy for cancer patients, particularly those with prostate cancer. The lab investigates how to target cancer cells while minimizing damage to healthy tissues by using novel prodrugs and nanotechnology. Their approach seeks to enhance the treatment's efficacy by delivering drugs specifically to dying cancer cells and developing imaging-guided strategies for better treatment outcomes.

Dr. Bo Wang's lab at Stanford University focuses on understanding the fundamental principles behind the ability of certain animals to regenerate body parts. They study various species, from planarians to flatworms, using advanced techniques to explore how regeneration works at the cellular level and how this knowledge can be applied to improve regenerative medicine for humans. By integrating genetics, live imaging, and mathematical modeling, the lab aims to uncover key mechanisms that can enhance tissue repair and regeneration.

Dr. Mark Schnitzer's lab at Stanford University focuses on understanding how different types of neurons in the brain interact and influence behavior. They have developed a groundbreaking robotic imaging system called the Octopus, which allows researchers to simultaneously observe neural activity in multiple regions of the brain. This technology aims to improve our understanding of brain function by enabling real-time imaging of genetically defined neuron types in awake animals.

Dr. Kerwyn C. Huang's lab at Stanford University focuses on understanding the small intestinal microbiota and its implications for human health. They are developing novel techniques to collect samples from the small intestine and create a comprehensive atlas of microbes residing there. This research aims to engineer therapies that utilize these microbes to improve health outcomes, especially in conditions like Crohn's disease and bacterial overgrowth.

Dr. Avnesh Sinh Thakor's research lab at Stanford University focuses on innovative therapies for transplant medicine and kidney injury. The lab develops new biomaterials and cell-based therapies to enhance the survival and function of transplanted islets and to treat acute kidney injury through mesenchymal stem cells. By incorporating advanced technologies, the lab aims to improve outcomes for patients undergoing these challenging medical treatments.

Dr. Kim Butts Pauly's lab focuses on using transcranial ultrasound stimulation (TUS) as a non-invasive method to treat substance use disorders by targeting specific brain regions like the nucleus accumbens. The lab aims to improve the precision and safety of TUS in human studies while addressing the challenges of auditory effects that might interfere with results. By designing better testing methods and waveforms, the research seeks to enhance the effectiveness of TUS for neurological interventions and ultimately contribute to innovative treatments.